Ghana FDA approves first locally manufactured oncology drug

The Food and Drugs Authority (FDA) has granted full marketing authorisation to the first oncology medication manufactured entirely in Ghana, a landmark for the country's pharmaceutical manufacturing sector.

FDA CEO Delese Mimi Darko said the drug — an oral chemotherapy agent for chronic myeloid leukaemia — had passed rigorous quality testing equivalent to international standards.

The manufacturer, Kinapharma Limited, invested over $12 million in upgrading its Accra facility to WHO GMP standards.